Clinical Trial Update: Serine Supplementation for Obese Subjects With Fatty Liver Disease [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial evaluating serine supplementation for obese individuals with non-alcoholic fatty liver disease has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• L-serine (L-serine)

Snippet

Sponsor: Hanns-Ulrich Marschall | Conditions: Non-alcoholic Fatty Liver Disease | Phase 1, Phase 2 | Status: COMPLETED